Mitigation of Multi-organ Delayed Effects of Acute Radiation Exposure (DEARE) with ACE-inhibitor Lisinopril
Award Notice Posted
- Solicitation number
- NIAID-BAA-75N93021R00019
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to The Medical College Of Wisconsin, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93023C00013 Federal contract award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Milwaukee, Wisconsin 53226, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Medical College of Wisconsin, Inc. was awarded a sole-source contract by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to conduct research mitigating the multi-organ delayed effects of acute radiation exposure through studying the effects of the hypertension drug lisinopril. Valued at $2,997,981, contract number 75N93023C00013 will support this research over its period to study the effects of lisinopril on delayed radiation exposure in multiple organ systems.
Notice text
Awarded contract 75N93023C00013 to The Medical College of Wisconsin, Inc. for 2997981.00 on 2023-07-01.
Notice history
10 of 12 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity